19 research outputs found
Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis
No full textVulnerability models for environmental risk assessment. Application to a nuclear power plant containment building
No full text
Geostatistical Simulation of Geochemical Compositions in the Presence of Multiple Geological Units: Application to Mineral Resource Evaluation
No full textESC 2021 Guideline on Cardiac Pacing and Resynchronization Therapy European Society of Cardiology (ESC) Working Group on Cardiac Pacing and Resynchronization Therapy (CRRT) of Cardiology (ESC)
No full text
Synthesis of Z-scheme Bi/TiO2/WO3·0.33H2O heterojunction material for the enhanced photocatalytic degradation of pollutants
No full textExpanding Indications for Resynchronization Therapy
No full textInternational audienceCardiac resynchronization therapy (CRT) is one of the major advances in the treatment of patients with chronic heart failure due to impaired left ventricular ejection fraction. Current guidelines recommend with the highest levels of recommendation and evidence CRT in patients with low ejection fraction wide QRS, LBBB, and mild to severe heart failure (New York Heart Association class II to IV). However, other patients might benefit from CRT. This is the case for patients with permanent atrial fibrillation, patients conventional pacemaker indication, patients with mildly impaired left ventricular function (>35Â %), or asymptomatic patients (NYHA I). We will discuss in this manuscript each new potential indication for CRT
